ArticleACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine2024
New Spatial Phenotypes from Imaging Uncover Survival Differences for Breast Cancer Patients.
Article in ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Imaging technologies have revolutionized the study of the tumor microenvironment (TME) by leveraging spatial analysis, which enables the exploration of tissue organization and cellular communication, as well as aiding cancer diagnosis and prognosis. However, while many advanced spatial analysis methods have been recently published, they are enmeshed with specific imaging technology. An opportunity exists to develop a technology-agnostic methodology that captures complex spatial patterns in the TME as phenotypes to use in downstream tasks. In this paper, we present a novel variation of spatial g-function and a comprehensive imaging-technology-agnostic framework that identifies rich spatial phenotypes that can be used in survival analysis and classification tasks. Applying our methodology to breast cancer, we uncover spatial phenotypes with significance to survival across racial groups and molecular subtypes of breast cancer. We find other phenotypes that are significant to the survival of specific patient categories (such as African American). We also demonstrate that our phenotypes reflect specific biological contexts. These results highlight the relevance of our proposed spatial analysis and phenotype discovery pipeline and demonstrate the benefits of the systematic exploration of spatial phenotypes for more personalized diagnosis and treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.